PD-L1 and TMB as biomarkers in the IMvigor211 trial of atezolizumab vs. chemo for bladder cancer
Severity of immune checkpoint inhibitors' side effects
The LUME BioNIS trial: an exploratory study into lung cancer biomarkers
Adjuvant chemotherapy for breast cancer: who needs it?
Topics highlighted at a chaired discussion on treatment and supportive care